AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone trials begin, page-6

  1. 5,902 Posts.
    lightbulb Created with Sketch. 17801
    The Company is preparing to re-enter the clinic to conduct a multi-dose trial with its lead product, oxycodone patch...

    Given this is the lead product, a more precise indication of when would have been nice.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $17 5.798K

Buyers (Bids)

No. Vol. Price($)
55 95690716 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59980558 19
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.